Myopia, or nearsightedness, continues to be a growing problem worldwide. Beyond needing glasses just to see clearly, unchecked myopia can increase the risk for future eye problems such as retinal detachment, glaucoma, and myopic macular degeneration.

Unlike standard single-vision glasses that only correct blurred distance vision, myopia management glasses use patented, specialized lenses that are designed to slow down the progression of nearsightedness. These advanced lenses work by subtly modifying how light focuses on the retina, reducing the visual cues that cause the eye to elongate over time.
Many innovative lens designs are now available globally, and the following represent a few of the most well-known and proven technologies:
Hoya MiYOSMART, which uses Defocus Incorporated Multiple Segments (DIMS) technology (not yet approved for use in U.S.)
Zeiss MyoCare, designed with an aspherical defocus profile (not yet approved for use in U.S.)
SightGlass Vision DOT, which incorporates micro-diffusion optics to reduce image contrast
Essilor Stellest, featuring Highly Aspherical Lenslet Target (H.A.L.T.) technology comprised of 1021 nearly invisible lenslets, which create a unique defocus, shown to slow progression by an average of 67%
Essilor Stellest is currently the only FDA-authorized myopia-control lens available in the U.S., though others are expected to follow as they complete regulatory approval. San Marcos Vision Center now has access to this new approved lens design.

To read more about the Stellest Lens, check out our comprehensive blog here.
Implementing myopia management with these specialized lenses should not be a “set it and forget it” approach. Proper fitting is necessary for treatment to be effective. Because these lenses are designed to influence eye growth, ongoing professional care is essential, which is also why FDA authorization is required for this type of medical technology. These treatments must be monitored and managed by an eye care professional to ensure safety and effectiveness.
The effectiveness of myopia management glasses should be closely monitored by an expert with extensive myopia management knowledge and specific myopia tracking technology. Many factors can influence the effectiveness of these new glasses, even down to properly fitting them on the child. When treatment is ineffective, changes should be identified and adjusted accordingly.
At San Marcos Vision Center, Dr. Mark Sturm has managed hundreds of children through personalized myopia-control programs. As an expert in complex Orthokeratology fitting and spectacle-lens management, Dr. Sturm offers a level of care few offices can match.
Our clinic uses the Pentacam AXL Wave, an advanced diagnostic system that precisely measures axial length and corneal shape, allowing us to track eye growth and treatment success over time.
Learn More About Pentacam
Parents should be cautious about starting myopia management in offices that do not measure axial length or fail to monitor ongoing treatment progress. Without these capabilities, it is impossible to confirm effectiveness.

At San Marcos Vision Center, we combine clinical expertise, advanced technology, and a deep commitment to children’s eye health to provide the highest standard of myopia management.
Modern myopia-control lenses, used in specialized myopia management glasses, have given us yet another tool in the toolbox to slow or halt myopia progression in your child. Book an appointment today and we will discuss whether Ortho-K, soft myopia control contacts, compounded atropine, or the newly approved myopia management glasses are best for your child.
Read more about the new Stellest Myopia Management Glasses here!
Call 512-353-0588 or visit www.sanmarcosvisioncenter.com to schedule a myopia-management consultation and learn which treatment option is best for your child.